<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Clinaptis Research Latest Press Releases</title>
<link>https://pressroom.prlog.org/clinaptis/</link>
<description>About Clinaptis Research - Independent biopharmaceutical intelligence platform focused on clinical data synthesis, therapeutic area research, valuation frameworks, market intelligence and digital research products for the life sciences industry.</description>
<item><title>Clinaptis Advisors Publishes Institutional Due Diligence on Structure Therapeutics' Aleniglipron</title>
<link>https://www.prlog.org/13163444-clinaptis-advisors-publishes-institutional-due-diligence-on-structure-therapeutics-aleniglipron.html</link>
<description>Independent analysis argues headline efficacy overstates competitive advantage, while concluding the overall clinical profile remains fundamentally credible.</description><pubDate>Sat, 08 Aug 2026 17:11:27 GMT</pubDate></item>
<item><title>Clinaptis Releases Research on Viking Therapeutics Drug Portfolio</title>
<link>https://www.prlog.org/13162692-clinaptis-releases-research-on-viking-therapeutics-drug-portfolio.html</link>
<description>Report develops a reverse-solve valuation framework separating VK2735's subcutaneous valuation floor from the unresolved commercial opportunity of the oral obesity program.</description><pubDate>Wed, 05 Aug 2026 01:44:49 GMT</pubDate></item>
</channel>
</rss>